CVS Health EBITDA Margin 2010-2025 | CVS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for CVS Health (CVS) over the last 10 years. The current EBITDA margin for CVS Health as of March 31, 2025 is .
| CVS Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $378.96B | $14.23B | 3.76% |
| 2024-12-31 | $372.81B | $13.11B | 3.52% |
| 2024-09-30 | $368.91B | $14.11B | 3.82% |
| 2024-06-30 | $363.25B | $16.93B | 4.66% |
| 2024-03-31 | $360.94B | $17.07B | 4.73% |
| 2023-12-31 | $357.78B | $18.11B | 5.06% |
| 2023-09-30 | $347.81B | $18.30B | 5.26% |
| 2023-06-30 | $339.20B | $10.62B | 3.13% |
| 2023-03-31 | $330.92B | $12.03B | 3.64% |
| 2022-12-31 | $322.47B | $12.18B | 3.78% |
| 2022-09-30 | $315.23B | $10.91B | 3.46% |
| 2022-06-30 | $307.86B | $18.41B | 5.98% |
| 2022-03-31 | $299.84B | $18.12B | 6.04% |
| 2021-12-31 | $292.11B | $18.23B | 6.24% |
| 2021-09-30 | $285.06B | $18.46B | 6.47% |
| 2021-06-30 | $278.32B | $18.19B | 6.54% |
| 2021-03-31 | $271.05B | $18.51B | 6.83% |
| 2020-12-31 | $268.71B | $18.35B | 6.83% |
| 2020-09-30 | $266.04B | $18.82B | 7.07% |
| 2020-06-30 | $263.80B | $18.48B | 7.01% |
| 2020-03-31 | $261.89B | $17.10B | 6.53% |
| 2019-12-31 | $256.78B | $16.36B | 6.37% |
| 2019-09-30 | $244.31B | $16.08B | 6.58% |
| 2019-06-30 | $226.99B | $15.26B | 6.72% |
| 2019-03-31 | $210.48B | $14.05B | 6.67% |
| 2018-12-31 | $194.58B | $12.89B | 6.62% |
| 2018-09-30 | $188.56B | $12.83B | 6.80% |
| 2018-06-30 | $187.25B | $12.75B | 6.81% |
| 2018-03-31 | $186.02B | $12.43B | 6.68% |
| 2017-12-31 | $184.79B | $12.20B | 6.60% |
| 2017-09-30 | $182.37B | $12.05B | 6.61% |
| 2017-06-30 | $180.81B | $12.37B | 6.84% |
| 2017-03-31 | $178.85B | $12.47B | 6.97% |
| 2016-12-31 | $177.55B | $12.86B | 7.24% |
| 2016-09-30 | $172.70B | $12.55B | 7.26% |
| 2016-06-30 | $166.73B | $11.97B | 7.18% |
| 2016-03-31 | $160.17B | $11.75B | 7.33% |
| 2015-12-31 | $153.29B | $11.57B | 7.55% |
| 2015-09-30 | $149.20B | $11.05B | 7.40% |
| 2015-06-30 | $145.58B | $10.91B | 7.49% |
| 2015-03-31 | $143.01B | $10.85B | 7.59% |
| 2014-12-31 | $139.37B | $10.73B | 7.70% |
| 2014-09-30 | $135.14B | $10.60B | 7.84% |
| 2014-06-30 | $132.05B | $10.49B | 7.94% |
| 2014-03-31 | $128.70B | $10.21B | 7.93% |
| 2013-12-31 | $126.76B | $9.91B | 7.82% |
| 2013-09-30 | $125.31B | $9.97B | 7.96% |
| 2013-06-30 | $123.61B | $9.61B | 7.78% |
| 2013-03-31 | $123.07B | $9.33B | 7.58% |
| 2012-12-31 | $123.12B | $8.96B | 7.28% |
| 2012-09-30 | $120.04B | $8.58B | 7.15% |
| 2012-06-30 | $116.48B | $8.31B | 7.13% |
| 2012-03-31 | $112.18B | $8.05B | 7.17% |
| 2011-12-31 | $107.08B | $7.90B | 7.38% |
| 2011-09-30 | $103.08B | $7.67B | 7.44% |
| 2011-06-30 | $100.12B | $7.52B | 7.51% |
| 2011-03-31 | $97.71B | $7.52B | 7.69% |
| 2010-12-31 | $95.78B | $7.61B | 7.94% |
| 2010-09-30 | $96.79B | $7.72B | 7.98% |
| 2010-06-30 | $97.72B | $7.74B | 7.92% |
| 2010-03-31 | $98.58B | $7.85B | 7.96% |
| 2009-12-31 | $98.22B | $7.81B | 7.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $81.948B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.605B | 27.50 |
| Elevance Health (ELV) | United States | $76.969B | 9.93 |
| Cencora (COR) | United States | $57.218B | 19.91 |
| DiDi Global (DIDIY) | China | $24.191B | 25.70 |
| Natera (NTRA) | United States | $21.906B | 0.00 |
| Labcorp Holdings (LH) | United States | $20.893B | 16.95 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.687B | 0.00 |
| CochLear (CHEOY) | Australia | $12.827B | 0.00 |
| Solventum (SOLV) | United States | $12.768B | 13.52 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.964B | 20.59 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Medpace Holdings (MEDP) | United States | $9.298B | 24.69 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| Sonic Healthcare (SKHHY) | Australia | $8.638B | 0.00 |
| HealthEquity (HQY) | United States | $8.174B | 35.80 |
| Charles River Laboratories (CRL) | United States | $7.829B | 15.34 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.744B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.911B | 28.92 |
| BrightSpring Health Services (BTSG) | United States | $3.571B | 32.76 |
| Sotera Health (SHC) | United States | $3.349B | 19.03 |
| Surgery Partners (SGRY) | United States | $2.825B | 36.73 |
| Alignment Healthcare (ALHC) | United States | $2.645B | 0.00 |
| Organon (OGN) | United States | $2.584B | 2.75 |
| Concentras Parent (CON) | United States | $2.551B | 14.74 |
| GeneDx Holdings (WGS) | United States | $2.356B | 90.73 |
| Ardent Health (ARDT) | United States | $2.027B | 8.64 |
| Progyny (PGNY) | United States | $1.990B | 43.79 |
| PACS (PACS) | United States | $1.932B | 0.00 |
| Premier (PINC) | United States | $1.736B | 13.18 |
| GoodRx Holdings (GDRX) | United States | $1.695B | 33.89 |
| Teladoc Health (TDOC) | United States | $1.460B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.298B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.127B | 8.58 |
| CareDx (CDNA) | United States | $1.121B | 17.50 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.810B | 7.58 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Embecta (EMBC) | United States | $0.612B | 4.12 |
| InnovAge Holding (INNV) | United States | $0.559B | 0.00 |
| SBC Medicals (SBC) | United States | $0.523B | 0.00 |
| LifeMD (LFMD) | United States | $0.512B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.455B | 0.00 | |
| So-Young (SY) | China | $0.390B | 0.00 |
| Enhabit (EHAB) | United States | $0.357B | 29.38 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.344B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.321B | 0.00 |
| Oncology Institute (TOI) | United States | $0.279B | 0.00 |
| Beauty Health (SKIN) | United States | $0.241B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Pheton Holdings (PTHL) | China | $0.138B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |